Study of High Risk Non Invasive Prenatal Test Population

• Conditions: Trisomy 21

• Registration Number: NCT04737070
• Lead Sponsor: Central Hospital, Nancy, France

Brief Summary

The investigator want to study the population of high risk (over 1/50) of Trisomy 21.

According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-01
• Study First Submitted: 2021-01-25
• Study First Submitted QC: 2021-01-31
• Last Update Submitted: 2021-01-31
• Study Start: 2021-02-01
• Study First Posted: 2021-02-03
• Last Update Posted: 2021-02-03
• Primary Completion: 2021-04-01
• Study Completion: 2021-07-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

• Prenatal screening of Trisomy 21 > 1/50 (high risk population)

Exclusion Criteria

• No exclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
number of genetics anomalies	through study completion, an average of 9 months